Site Members can sign up for company wide alerts
Investigation Overview
After Valeant Pharmaceuticals Intl, Inc. announced it intended to take over Cephalon, Inc. at $73 per CEPH share an investigation on behalf of investors in Cephalon, Inc. (NASDAQ:CEPH) concerning possible breaches of fiduciary duty was announced. The investigation by a law firm concerns whether certain directors and officers at Cephalon, Inc. or others breached or will breach their fi...
You must register (for free) or login to view the entire investigation.